心脉医疗：累计回购公司股份1228743股

Group 1 - The core point of the article is that Xinmai Medical announced the completion of a share buyback program, having repurchased a total of 1,228,743 shares as of August 31, 2025, through the Shanghai Stock Exchange trading system [1] Group 2 - The share buyback was conducted via centralized bidding trading method, indicating a strategic move by the company to enhance shareholder value [1] - The announcement was made on the evening of September 2, highlighting the company's proactive communication with investors [1] - The buyback program is part of the company's ongoing efforts to manage its capital structure and potentially improve stock performance [1]